BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12851933)

  • 1. Improvement of hepatocyte-specific gene expression by a targeted colchicine prodrug.
    van Rossenberg SM; Sliedregt-Bol KM; Koning G; van den Elst H; van Berkel TJ; van Boom JH; van der Marel GA; Biessen EA
    Chembiochem; 2003 Jul; 4(7):633-9. PubMed ID: 12851933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted delivery of oligodeoxynucleotides to parenchymal liver cells in vivo.
    Biessen EA; Vietsch H; Rump ET; Fluiter K; Kuiper J; Bijsterbosch MK; van Berkel TJ
    Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):783-92. PubMed ID: 10359665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A targeted peptide nucleic acid to down-regulate mouse microsomal triglyceride transfer protein expression in hepatocytes.
    van Rossenberg SM; Sliedregt-Bol KM; Prince P; van Berkel TJ; van Boom JH; van der Marel GA; Biessen EA
    Bioconjug Chem; 2003; 14(6):1077-82. PubMed ID: 14624620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A hepatocyte-targeted conjugate capable of delivering biologically active colchicine in vitro.
    Plourde R; Phillips AT; Wu CH; Hays RM; Chowdhury J; Chowdhury N; Wu GY
    Bioconjug Chem; 1996; 7(1):131-7. PubMed ID: 8742001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of co-modified liver-targeting liposomes as gene delivery carriers based on cellular uptake and antigens inhibition effect.
    Zhang Y; Rong Qi X; Gao Y; Wei L; Maitani Y; Nagai T
    J Control Release; 2007 Feb; 117(2):281-90. PubMed ID: 17196291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of a targeted peptide nucleic acid prodrug to inhibit hepatic human microsomal triglyceride transfer protein expression in hepatocytes.
    Biessen EA; Sliedregt-Bol K; 'T Hoen PA; Prince P; Van der Bilt E; Valentijn AR; Meeuwenoord NJ; Princen H; Bijsterbosch MK; Van der Marel GA; Van Boom JH; Van Berkel TJ
    Bioconjug Chem; 2002; 13(2):295-302. PubMed ID: 11906267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted lysosome disruptive elements for improvement of parenchymal liver cell-specific gene delivery.
    Van Rossenberg SM; Sliedregt-Bol KM; Meeuwenoord NJ; Van Berkel TJ; Van Boom JH; Van Der Marel GA; Biessen EA
    J Biol Chem; 2002 Nov; 277(48):45803-10. PubMed ID: 12237290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced hepatocyte-selective in vivo gene expression by stabilized galactosylated liposome/plasmid DNA complex using sodium chloride for complex formation.
    Fumoto S; Kawakami S; Ito Y; Shigeta K; Yamashita F; Hashida M
    Mol Ther; 2004 Oct; 10(4):719-29. PubMed ID: 15451456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Acetylgalactosamine Block-co-Polycations Form Stable Polyplexes with Plasmids and Promote Liver-Targeted Delivery.
    Dhande YK; Wagh BS; Hall BC; Sprouse D; Hackett PB; Reineke TM
    Biomacromolecules; 2016 Mar; 17(3):830-40. PubMed ID: 26854615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjugation of mono and di-GalNAc sugars enhances the potency of antisense oligonucleotides via ASGR mediated delivery to hepatocytes.
    Kinberger GA; Prakash TP; Yu J; Vasquez G; Low A; Chappell A; Schmidt K; Murray HM; Gaus H; Swayze EE; Seth PP
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3690-3. PubMed ID: 27268307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic lactose-functionalization of amphiphilic octaamine macrocycle as a gene carrier. Optimization of the charge, size, toxicity, and receptor factors for hepatocyte targeting.
    Horiuchi S; Aoyama Y
    J Control Release; 2006 Nov; 116(2):107-14. PubMed ID: 16905218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galactosylated ternary DNA/polyphosphoramidate nanoparticles mediate high gene transfection efficiency in hepatocytes.
    Zhang XQ; Wang XL; Zhang PC; Liu ZL; Zhuo RX; Mao HQ; Leong KW
    J Control Release; 2005 Feb; 102(3):749-63. PubMed ID: 15681095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and transcriptional activities of nuclear receptors involved in regulation of drug-metabolizing enzymes are not altered by colchicine: focus on PXR, CAR, and GR in primary human hepatocytes.
    Dvorák Z; Maurel P; Vilarem MJ; Ulrichová J; Modrianský M
    Cell Biol Toxicol; 2007 Mar; 23(2):63-73. PubMed ID: 16964586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrodynamic-based in vivo transfection of retinoic X receptor-alpha gene can enhance vitamin A-induced attenuation of liver fibrosis in mice.
    Chen C; Zhang J; Li J; Huang J; Yang C; Huang G; Shi J
    Liver Int; 2004 Dec; 24(6):679-86. PubMed ID: 15566521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid hormone (T3)-modification of polyethyleneglycol (PEG)-polyethyleneimine (PEI) graft copolymers for improved gene delivery to hepatocytes.
    Rudolph C; Sieverling N; Schillinger U; Lesina E; Plank C; Thünemann AF; Schönberger H; Rosenecker J
    Biomaterials; 2007 Apr; 28(10):1900-11. PubMed ID: 17196251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of a novel legumain-cleavable colchicine prodrug with cell-specific toxicity.
    Smith RL; Åstrand OA; Nguyen LM; Elvestrand T; Hagelin G; Solberg R; Johansen HT; Rongved P
    Bioorg Med Chem; 2014 Jul; 22(13):3309-15. PubMed ID: 24842619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 99mTc-neolactosylated human serum albumin for imaging the hepatic asialoglycoprotein receptor.
    Jeong JM; Hong MK; Lee J; Son M; So Y; Lee DS; Chung JK; Lee MC
    Bioconjug Chem; 2004; 15(4):850-5. PubMed ID: 15264873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New and more efficient multivalent glyco-ligands for asialoglycoprotein receptor of mammalian hepatocytes.
    Lee RT; Wang MH; Lin WJ; Lee YC
    Bioorg Med Chem; 2011 Apr; 19(8):2494-500. PubMed ID: 21459583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic delivery of particulates in the submicron range by a hydrodynamics-based procedure: implications for particulate gene delivery systems.
    Kobayashi N; Hirata K; Chen S; Kawase A; Nishikawa M; Takakura Y
    J Gene Med; 2004 Apr; 6(4):455-63. PubMed ID: 15079820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and characterization of a novel liver-targeted prodrug of cytosine-1-beta-D-arabinofuranoside monophosphate for the treatment of hepatocellular carcinoma.
    Boyer SH; Sun Z; Jiang H; Esterbrook J; Gómez-Galeno JE; Craigo W; Reddy KR; Ugarkar BG; MacKenna DA; Erion MD
    J Med Chem; 2006 Dec; 49(26):7711-20. PubMed ID: 17181153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.